ADAM17 and atherosclerosis: Conversely, by targeting the ADAM17/TNF axis, overexpression of TIMP-3 in mouse macrophages reduced adipose inflammation, insulin resistance and nonalcoholic fatty liver disease, other than reducing atherosclerotic plaques in a mouse model of atherosclerosis [89,90,91].